Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

3.1K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-Candida fungal cholecystitis - an uncommon occurrence even in the right host.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
Same author

Cryptosporidiosis in inborn errors of immunity: a single center cohort and review of the literature.

The Journal of infectious diseases·2026
Same author

Allogeneic hematopoietic cell transplantation in mature T- or NK-lymphomas: a phase II clinical trial.

Nature communications·2026
Same author

Pre- and peri-hematopoietic cell transplant management of disseminated non-Helicobacter pylori Helicobacter infection in X-linked agammaglobulinemia: Case series and literature review.

Clinical immunology (Orlando, Fla.)·2026
Same author

Malaria Screening and Treatment in Hematopoietic Cell Transplant Donors and Sickle Cell Disease Candidates/Recipients: A Case Series Using Malaria Polymerase Chain Reaction Testing and a Literature Review.

Transplant infectious disease : an official journal of the Transplantation Society·2025
Same author

Usefulness and Limitations of Polymerase Chain Reaction (PCR) for the Diagnosis and Management of Toxoplasmosis Following Allogeneic Hematopoietic Cell Transplant: Single-center Experience With 31 Patients Over 16 Years.

Open forum infectious diseases·2025

Related Experiment Video

Updated: Jun 5, 2025

Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung
15:01

Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung

Published on: September 18, 2021

3.3K

Mucormycosis.

Mary M Czech1, Jennifer Cuellar-Rodriguez2

  • 1National Institute of Allergy and Infectious Diseases, National Institutes of Health, 10 Center Drive, Building 10 2C146B, Bethesda, MD 20892, USA.

Infectious Disease Clinics of North America
|December 5, 2024
PubMed
Summary
This summary is machine-generated.

Mucormycosis is a dangerous fungal infection often seen in patients with uncontrolled diabetes or weakened immune systems. Early diagnosis through clinical signs, imaging, and molecular methods is crucial for effective multidisciplinary treatment.

Keywords:
AmphotericinDiabetesIsavuconazoleMucormycosisPosaconazole

More Related Videos

Th17 Inflammation Model of Oropharyngeal Candidiasis in Immunodeficient Mice
08:02

Th17 Inflammation Model of Oropharyngeal Candidiasis in Immunodeficient Mice

Published on: February 18, 2015

9.9K
Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
06:39

Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis

Published on: October 27, 2023

879

Related Experiment Videos

Last Updated: Jun 5, 2025

Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung
15:01

Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung

Published on: September 18, 2021

3.3K
Th17 Inflammation Model of Oropharyngeal Candidiasis in Immunodeficient Mice
08:02

Th17 Inflammation Model of Oropharyngeal Candidiasis in Immunodeficient Mice

Published on: February 18, 2015

9.9K
Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
06:39

Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis

Published on: October 27, 2023

879

Area of Science:

  • Mycology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Mucormycosis is an aggressive, often fatal fungal infection.
  • Commonly affects individuals with uncontrolled diabetes mellitus and hematologic malignancy.
  • Patients present with rhino-orbito-cerebral, pulmonary, or other disseminated diseases.

Purpose of the Study:

  • To highlight the critical need for prompt recognition and diagnosis of mucormycosis.
  • To discuss the evolving diagnostic approaches, including molecular methods.
  • To outline the multidisciplinary treatment strategies for mucormycosis.

Main Methods:

  • Review of clinical presentations and risk factors associated with mucormycosis.
  • Discussion of traditional diagnostic methods (microscopy, culture, pathology).
  • Emphasis on the growing role of molecular diagnostic techniques.

Main Results:

  • Mucormycosis requires rapid identification due to its aggressive nature.
  • Diabetes mellitus and immunosuppression are primary risk factors.
  • Timely diagnosis improves treatment outcomes.

Conclusions:

  • Prompt clinical and radiographic recognition is essential for early mucormycosis diagnosis.
  • Molecular methods offer potential for earlier and more accurate diagnosis.
  • Multidisciplinary management, including surgery, antifungals, and risk factor correction, is key to patient survival.